
Am J Psychiatry 163:418-425, March 2006
doi: 10.1176/appi.ajp.163.3.418
© 2006 American Psychiatric Association
Determinants of Real-World Functional Performance in Schizophrenia Subjects: Correlations With Cognition, Functional Capacity, and Symptoms
Christopher R. Bowie, Ph.D.,
Abraham Reichenberg, Ph.D.,
Thomas L. Patterson, Ph.D.,
Robert K. Heaton, Ph.D., and
Philip D. Harvey, Ph.D.
OBJECTIVE: Impairments in adaptive life skills are a major source of disability in patients with schizophrenia. The relationship between adaptive life skills in real-world settings and performance on neuropsychological tests may be complicated by other factors that interfere with deployment of skills. Assessment of the ability to perform life skills under optimal conditions (i.e., assessment of functional capacity) has been proposed as a means to clarify these relationships. METHOD: The authors examined cross-sectional data from a study of the course of neuropsychological and adaptive life skills of older (age 5085) schizophrenia patients (N=78). Functional capacity was examined with a performance-based measure (UCSD Performance-Based Skills Assessment), and case managers rated real-world adaptive functions (i.e., interpersonal skills, work skills, and community activities). Neuropsychological performance was assessed with a comprehensive battery, while symptoms were assessed with patient self-report and clinical ratings. RESULTS: Confirmatory path analyses were used to evaluate the effects of neuropsychological performance, functional capacity, and symptoms on the various domains of real-world functioning. Neuropsychological performance predicted functional capacity, which predicted all three domains of real-world functioning. Depression predicted interpersonal and work skills, while negative symptoms affected interpersonal skills independently of other predictors. CONCLUSIONS: Real-world adaptive life skills are predicted by neuropsychological performance, symptoms, and functional capacity. Neuropsychological performance contributes little to the prediction of real-world performance after accounting for functional capacity. In some domains, negative and depressive symptoms influenced real-world performance while not relating to functional capacity or neuropsychological performance.
This article has been cited by other articles:

|
 |

|
 |
 
G. Foussias and G. Remington
Negative Symptoms in Schizophrenia: Avolition and Occam's Razor
Schizophr Bull,
July 21, 2008;
(2008)
sbn094v1.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
P. D. HARVEY
Dr. Harvey Replies
Am J Psychiatry,
June 1, 2008;
165(6):
772 - 772.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. F. Green, K. H. Nuechterlein, R. S. Kern, L. E. Baade, W. S. Fenton, J. M. Gold, R. S.E. Keefe, R. Mesholam-Gately, L. J. Seidman, E. Stover, et al.
Functional Co-Primary Measures for Clinical Trials in Schizophrenia: Results From the MATRICS Psychometric and Standardization Study
Am J Psychiatry,
February 1, 2008;
165(2):
221 - 228.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
B. T. Mausbach, P. D. Harvey, S. R. Goldman, D. V. Jeste, and T. L. Patterson
Development of a Brief Scale of Everyday Functioning in Persons with Serious Mental Illness
Schizophr Bull,
November 1, 2007;
33(6):
1364 - 1372.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
T. E. Goldberg, R. S. Goldman, K. E. Burdick, A. K. Malhotra, T. Lencz, R. C. Patel, M. G. Woerner, N. R. Schooler, J. M. Kane, and D. G. Robinson
Cognitive Improvement After Treatment With Second-Generation Antipsychotic Medications in First-Episode Schizophrenia: Is It a Practice Effect?
Arch Gen Psychiatry,
October 1, 2007;
64(10):
1115 - 1122.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
D. Dickinson, A. S. Bellack, and J. M. Gold
Social/Communication Skills, Cognition, and Vocational Functioning in Schizophrenia
Schizophr Bull,
September 1, 2007;
33(5):
1213 - 1220.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
P. D. Harvey, D. I. Velligan, and A. S. Bellack
Performance-Based Measures of Functional Skills: Usefulness in Clinical Treatment Studies
Schizophr Bull,
September 1, 2007;
33(5):
1138 - 1148.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. F. Green
Cognition, Drug Treatment, and Functional Outcome in Schizophrenia: A Tale of Two Transitions
Am J Psychiatry,
July 1, 2007;
164(7):
992 - 994.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
R. S. E. Keefe and W. S. Fenton
How Should DSM-V Criteria for Schizophrenia Include Cognitive Impairment?
Schizophr Bull,
July 1, 2007;
33(4):
912 - 920.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. S. Bellack, M. F. Green, J. A. Cook, W. Fenton, P. D. Harvey, R. K. Heaton, T. Laughren, A. C. Leon, D. J. Mayo, D. L. Patrick, et al.
Assessment of Community Functioning in People With Schizophrenia and Other Severe Mental Illnesses: A White Paper Based on an NIMH-Sponsored Workshop
Schizophr Bull,
May 1, 2007;
33(3):
805 - 822.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
R. W. Buchanan
Important Steps in the Development of Cognitive-Enhancing Drugs in Schizophrenia
Am J Psychiatry,
November 1, 2006;
163(11):
1867 - 1869.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
P. D. Harvey, T. L. Patterson, L. S. Potter, K. Zhong, and M. Brecher
Improvement in Social Competence With Short-Term Atypical Antipsychotic Treatment: A Randomized, Double-Blind Comparison of Quetiapine Versus Risperidone for Social Competence, Social Cognition, and Neuropsychological Functioning
Am J Psychiatry,
November 1, 2006;
163(11):
1918 - 1925.
[Abstract]
[Full Text]
[PDF]
|
 |
|
Get information about faster international access.
a>
Privacy Policy
Copyright © 2006
American Psychiatric Association.
All rights reserved.
Home
| Search
| Current Issue
| Past Issues
| Subscribe
| All APPI Journals
| Help
| Contact Us
|